• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中 p53/miR-34a/CSF1R/STAT3 反馈回路的特征。

Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.

机构信息

Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.

Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany; German Cancer Consortium, Partner site Munich, Munich, Germany; German Cancer Research Center, Heidelberg, Germany.

出版信息

Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15.

DOI:10.1016/j.jcmgh.2020.04.002
PMID:32304779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7423584/
Abstract

BACKGROUND & AIMS: The miR-34a gene is a direct target of p53 and is commonly silenced in colorectal cancer (CRC). Here we identified the receptor tyrosine kinase CSF1R as a direct miR-34a target and characterized CSF1R as an effector of p53/miR-34a-mediated CRC suppression.

METHODS

Analyses of TCGA-COAD and three other CRC cohorts for association of mRNA expression and signatures with patient survival and molecular subtypes. Bioinformatics identification and experimental validation of miRNA and transcription factor targets. Functional analysis of factors/pathways in the regulation of epithelial-mesenchymal transition (EMT), invasion, migration, acquired chemo-resistance and metastasis. Analyses of protein expression and CpG methylation within primary human colon cancer samples.

RESULTS

In primary CRCs increased CSF1R, CSF1 and IL34 expression was associated with poor patient survival and a mesenchymal-like subtype. CSF1R displayed an inverse correlation with miR-34a expression. This was explained by direct inhibition of CSF1R by miR-34a. Furthermore, p53 repressed CSF1R via inducing miR-34a, whereas SNAIL induced CSF1R both directly and indirectly via repressing miR-34a in a coherent feed-forward loop. Activation of CSF1R induced EMT, migration, invasion and metastasis of CRC cells via STAT3-mediated down-regulation of miR-34a. 5-FU resistance of CRC cells was mediated by CpG-methylation of miR-34a and the resulting elevated expression of CSF1R. In primary CRCs elevated expression of CSF1R was detected at the tumor invasion front and was associated with CpG methylation of the miR-34a promoter as well as distant metastasis.

CONCLUSIONS

The reciprocal inhibition between miR-34a and CSF1R and its loss in tumor cells may be relevant for therapeutic and prognostic approaches towards CRC management.

摘要

背景与目的

miR-34a 基因是 p53 的直接靶标,在结直肠癌(CRC)中通常被沉默。在这里,我们确定了受体酪氨酸激酶 CSF1R 是 miR-34a 的直接靶标,并将 CSF1R 鉴定为 p53/miR-34a 介导的 CRC 抑制的效应物。

方法

分析 TCGA-COAD 和另外三个 CRC 队列中 mRNA 表达和特征与患者生存和分子亚型的关联。miRNA 和转录因子靶标的生物信息学鉴定和实验验证。上皮-间充质转化(EMT)、侵袭、迁移、获得化疗耐药和转移调节中的因素/途径的功能分析。分析原发性人结肠癌样本中的蛋白表达和 CpG 甲基化。

结果

在原发性 CRC 中,CSF1R、CSF1 和 IL34 的表达增加与患者生存不良和间充质样亚型相关。CSF1R 与 miR-34a 的表达呈负相关。这可以通过 miR-34a 直接抑制 CSF1R 来解释。此外,p53 通过诱导 miR-34a 来抑制 CSF1R,而 SNAIL 通过直接和间接抑制 miR-34a 在一个一致的正反馈环中诱导 CSF1R。CSF1R 的激活通过 STAT3 介导的 miR-34a 下调诱导 CRC 细胞的 EMT、迁移、侵袭和转移。CRC 细胞对 5-FU 的耐药性是通过 miR-34a 的 CpG 甲基化和 CSF1R 的表达升高介导的。在原发性 CRC 中,在肿瘤侵袭前沿检测到 CSF1R 的高表达,并与 miR-34a 启动子的 CpG 甲基化以及远处转移相关。

结论

miR-34a 和 CSF1R 之间的相互抑制及其在肿瘤细胞中的缺失可能与 CRC 管理的治疗和预后方法相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/ef90f2a626cf/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/d2257c113c4d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/512cfdf81bc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/5f687620c716/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/4b6b89db27d6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/10385e976c9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/fa19b875cfdb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/1d9fc4f1561d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/9163d4bd2aaf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/0db77b718436/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/115c4541d3eb/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/e2aa59a19e36/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/813ad50f7eeb/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/ef90f2a626cf/gr12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/d2257c113c4d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/512cfdf81bc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/5f687620c716/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/4b6b89db27d6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/10385e976c9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/fa19b875cfdb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/1d9fc4f1561d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/9163d4bd2aaf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/0db77b718436/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/115c4541d3eb/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/e2aa59a19e36/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/813ad50f7eeb/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9486/7423584/ef90f2a626cf/gr12.jpg

相似文献

1
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.结直肠癌中 p53/miR-34a/CSF1R/STAT3 反馈回路的特征。
Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15.
2
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.IL-6R/STAT3/miR-34a 反馈环促进 EMT 介导的结直肠癌侵袭和转移。
J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18.
3
mediates enhancement of intestinal tumorigenesis caused by inactivation of .介导 APC 失活引起的肠道肿瘤发生增强
Int J Biol Sci. 2022 Aug 29;18(14):5415-5437. doi: 10.7150/ijbs.75503. eCollection 2022.
4
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.p53 和 HIF1A 对 miR-34a 调控 PPP1R11 和 STAT3 及缺氧诱导的结直肠癌细胞上皮间质转化的拮抗作用。
Gastroenterology. 2017 Aug;153(2):505-520. doi: 10.1053/j.gastro.2017.04.017. Epub 2017 Apr 20.
5
Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis.旁分泌诱导结直肠癌细胞上皮-间充质转化及其被 p53/miR-192/215/NID1 轴抑制。
Cell Mol Gastroenterol Hepatol. 2019;7(4):783-802. doi: 10.1016/j.jcmgh.2019.02.003. Epub 2019 Mar 1.
6
CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.CRISPR/Cas9 介导的 miR-34a 和 miR-34b/c 在 HCT116 结直肠癌细胞中的失活:5-FU 暴露后的综合表征揭示 EMT 和自噬是 miR-34 调控的关键过程。
Cell Death Differ. 2023 Aug;30(8):2017-2034. doi: 10.1038/s41418-023-01193-2. Epub 2023 Jul 24.
7
SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.SNAIL 和 miR-34a 的正反馈调节促进了 ZNF281/ZBP99 的上皮-间充质转化。
EMBO J. 2013 Nov 27;32(23):3079-95. doi: 10.1038/emboj.2013.236. Epub 2013 Nov 1.
8
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions.miR-34 和 SNAIL 形成双重负反馈回路以调节上皮-间充质转化。
Cell Cycle. 2011 Dec 15;10(24):4256-71. doi: 10.4161/cc.10.24.18552.
9
GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.GDPD5 是 miR-195-5p 的靶标,与结直肠癌的转移和化疗耐药有关。
Biomed Pharmacother. 2018 May;101:945-952. doi: 10.1016/j.biopha.2018.03.028. Epub 2018 Mar 22.
10
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.p53对c-Kit的抑制作用由miR-34介导,且与化疗耐药性降低、迁移能力及干性相关。
Oncotarget. 2013 Sep;4(9):1399-415. doi: 10.18632/oncotarget.1202.

引用本文的文献

1
The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic Implications.STAT3在结肠疾病中的意义:病理作用与治疗意义的综合研究
Cell Biochem Biophys. 2025 Jul 8. doi: 10.1007/s12013-025-01816-0.
2
Role of FHOD1 in tumor cells and tumor immune microenvironment.FHOD1在肿瘤细胞和肿瘤免疫微环境中的作用。
Front Immunol. 2025 Apr 29;16:1514488. doi: 10.3389/fimmu.2025.1514488. eCollection 2025.
3
Epigenetically Regulating Non-coding RNAs in Colorectal Cancer: Promises and Potentials.

本文引用的文献

1
Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.肿瘤特异性 p53 缺失导致髓系和 T 细胞反应的调节。
Cell Rep. 2020 Jan 14;30(2):481-496.e6. doi: 10.1016/j.celrep.2019.12.028.
2
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF amplification whereas KRAS amplification promotes EMT-chemoresistance.MEK1/2 抑制剂停药可逆转由 BRAF 扩增驱动的获得性耐药,而 KRAS 扩增则促进 EMT-化疗耐药。
Nat Commun. 2019 May 2;10(1):2030. doi: 10.1038/s41467-019-09438-w.
3
Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.
结直肠癌中表观遗传调控的非编码RNA:前景与潜力
Middle East J Dig Dis. 2025 Jan;17(1):40-53. doi: 10.34172/mejdd.2025.404. Epub 2025 Jan 31.
4
Prognostic and predictive molecular biomarkers in colorectal cancer.结直肠癌的预后和预测分子生物标志物
Front Oncol. 2025 Apr 16;15:1532924. doi: 10.3389/fonc.2025.1532924. eCollection 2025.
5
The role of intestinal macrophage polarization in colitis-associated colon cancer.肠道巨噬细胞极化在结肠炎相关结肠癌中的作用。
Front Immunol. 2025 Mar 5;16:1537631. doi: 10.3389/fimmu.2025.1537631. eCollection 2025.
6
Role of the p53/miR-34a/SIRT1 Feedback Loop in Metformin-induced Radiosensitivity of Colorectal Cancer Cells.p53/miR-34a/SIRT1反馈环在二甲双胍诱导的结肠癌细胞放射敏感性中的作用
Curr Radiopharm. 2025 Feb 4. doi: 10.2174/0118744710331660250127115004.
7
MiRNAs as major players in brain health and disease: current knowledge and future perspectives.微小RNA作为大脑健康与疾病的主要参与者:当前认知与未来展望
Cell Death Discov. 2025 Jan 13;11(1):7. doi: 10.1038/s41420-024-02283-x.
8
Insights into CSF-1R Expression in the Tumor Microenvironment.对肿瘤微环境中集落刺激因子1受体(CSF-1R)表达的见解。
Biomedicines. 2024 Oct 18;12(10):2381. doi: 10.3390/biomedicines12102381.
9
Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.髓系细胞中的Mir34a抑制结肠炎相关结肠癌:通过单细胞RNA测序对介质进行表征
Cell Death Differ. 2025 Feb;32(2):225-241. doi: 10.1038/s41418-024-01380-9. Epub 2024 Oct 18.
10
Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications.靶向髓系来源抑制细胞中的 CSF1R:其在结直肠癌中的免疫调节功能及治疗意义。
J Nanobiotechnology. 2024 Jul 11;22(1):409. doi: 10.1186/s12951-024-02584-4.
核集落刺激因子 1 受体在人单核细胞和巨噬细胞中的动态基因调控。
Nat Commun. 2019 Apr 26;10(1):1935. doi: 10.1038/s41467-019-09970-9.
4
A framework for the development of effective anti-metastatic agents.一种有效的抗转移药物的开发框架。
Nat Rev Clin Oncol. 2019 Mar;16(3):185-204. doi: 10.1038/s41571-018-0134-8.
5
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.联合敲除 TP53 和 MIR34A 通过增加 IL6R 和 PAI1 的水平促进小鼠结直肠癌的发生和发展。
Gastroenterology. 2018 Dec;155(6):1868-1882. doi: 10.1053/j.gastro.2018.08.011. Epub 2018 Aug 10.
6
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.白细胞介素-34维持结肠癌组织中的促肿瘤信号。
Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.
7
EMT in cancer.肿瘤中的 EMT。
Nat Rev Cancer. 2018 Feb;18(2):128-134. doi: 10.1038/nrc.2017.118. Epub 2018 Jan 12.
8
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.结直肠癌共识分子亚型转化为临床前模型揭示了潜在可靶向的癌细胞依赖性。
Clin Cancer Res. 2018 Feb 15;24(4):794-806. doi: 10.1158/1078-0432.CCR-17-1234. Epub 2017 Dec 14.
9
An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer.粒细胞巨噬细胞集落刺激因子在结肠癌中诱导上皮-间充质转化的潜能。
Sci Rep. 2017 Aug 15;7(1):8265. doi: 10.1038/s41598-017-08047-1.
10
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.集落刺激因子 1 受体(CSF1R)抑制剂在癌症治疗中的应用。
J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y.